Brave Asset Management’s Eastman Chemical EMN Stock Holding History

Brave Asset Management’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-670	Closed	-$45K	–	197
2016 Q3	$45K	Hold	670	–	–	0.03%	221
2016 Q2	$45K	Hold	670	–	–	0.03%	221
2016 Q1	$48K	Hold	670	–	–	0.03%	217
2015 Q4	$45K	Hold	670	–	–	0.03%	228
2015 Q3	$43K	Hold	670	–	–	0.03%	223
2015 Q2	$55K	Hold	670	–	–	0.04%	219
2015 Q1	$46K	Hold	670	–	–	0.03%	230
2014 Q4	$51K	Hold	670	–	–	0.04%	224
2014 Q3	$54K	Hold	670	–	–	0.04%	210
2014 Q2	$59K	Hold	670	–	–	0.04%	206
2014 Q1	$58K	Hold	670	–	–	0.05%	201
2013 Q4	$54K	Buy	+670	New	+$52K	0.04%	207

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brave Asset Management's EMN Position: Q4 2016 in Review

Brave Asset Management sold out of Eastman Chemical (EMN) in Q4 2016, closing a stake of 670 shares — an estimated $45K sold.

Brave Asset Management first reported a position in EMN in Q4 2013 and held it in 12 quarters. The position peaked at $59K in Q2 2014. 608 funds tracked by Wall St. Rank hold EMN as of Q4 2016.

Brave Asset Management reported no remaining Eastman Chemical position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 670 Eastman Chemical shares in Q4 2016, an estimated $45K.
Brave Asset Management first reported a position in Eastman Chemical in Q4 2013 and held it in 12 quarters.
Brave Asset Management's Eastman Chemical position peaked at $59K in Q2 2014.
608 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.